Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ABIOMED, Inc.    ABMD

ABIOMED, INC. (ABMD)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

Abiomed : invests in Israeli medical device maker Magenta

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 01:06pm CEST

JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

Japanese venture capital group JAFCO and a group of cardiovascular experts also invested in the round.

The Israeli startup is developing an apparatus for treating acute heart failure which it says can alleviate congestion faster and more safely than diuretics alone. Heart failure afflicts approximately 6.5 million people in the United States alone.

Ehud Schwammenthal, Magenta's co-founder and chief medical officer, said the company's first product was in clinical trials in Europe. The funding, he said, will allow the firm to expand the clinical programme, with the goal of getting approval in Europe and a second study going in the United States.

(Reporting by Dan Pleck; Editing by Tova Cohen)

Stocks treated in this article : ABIOMED, Inc., Medtronic PLC
Stocks mentioned in the article
ChangeLast1st jan.
ABIOMED, INC. 0.05% 376.75 Delayed Quote.100.93%
MEDTRONIC PLC -0.43% 96.46 Delayed Quote.19.98%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABIOMED, INC.
02:30pABIOMED : to Showcase Expanded FDA Indications and Next Generation Heart Recover..
AQ
09/19ABIOMED : to Showcase Expanded FDA Indications and Next Generation Heart Recover..
AQ
09/06ABIOMED : MILITARY $50,251 Federal Contract Awarded to Abiomed
AQ
08/28ABIOMED : MILITARY $25,126 Federal Contract Awarded to Abiomed
AQ
08/14ABIOMED : MILITARY $75,000 Federal Contract Awarded to Abiomed
AQ
08/14ABIOMED : MILITARY $75,377 Federal Contract Awarded to Abiomed
AQ
08/10ABIOMED INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
08/03ABIOMED INC : Other Events (form 8-K)
AQ
08/02ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
07/30ABIOMED : Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior..
AQ
More news
News from SeekingAlpha
08/27Corvia Medical's interatrial shunt shows positive effect in heart failure pat.. 
08/23Is ICU Medical A Better Bet Than ABIOMED? 
08/22Best And Worst S&P 500 Stocks On The Road To Nowhere 
08/12S&P 500 : It's All In The Numbers And The Numbers Never Lie 
08/06Abiomed Is Another Intuitive Surgical In The Making - Is This Your Chance To .. 
Financials ($)
Sales 2019 771 M
EBIT 2019 218 M
Net income 2019 204 M
Finance 2019 533 M
Yield 2019 -
P/E ratio 2019 83,85
P/E ratio 2020 78,33
EV / Sales 2019 21,3x
EV / Sales 2020 16,3x
Capitalization 16 907 M
Chart ABIOMED, INC.
Duration : Period :
ABIOMED, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 449 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer
Todd A. Trapp Chief Financial Officer & Vice President
Thorsten Siess Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED, INC.100.93%16 907
THERMO FISHER SCIENTIFIC25.92%97 098
DANAHER CORPORATION15.83%75 231
INTUITIVE SURGICAL52.48%63 297
BOSTON SCIENTIFIC CORPORATION51.75%51 846
ILLUMINA60.59%51 504